Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Dec 2023 for POINT Biopharma Global Inc.. Read the official filing
Filing timeline
BuySaleYael Margolin
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Yael Margolin: trading record in brief
Yael Margolin appears in our data through filings on POINT Biopharma Global Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 21 November 2022 and the latest from 27 December 2023.
Every open-market trade on record is a purchase: 1 purchase worth €11k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 27 December 2023, reports a transaction in POINT Biopharma Global Inc. The most recent open-market purchase was published on 23 November 2022, 1,425 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Yael Margolin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,710 sharesCommon StockSEC:0001104659-23-129766:0
1,710 shares@ US$6.56100.0% of flowCommon StockSEC:0001104659-22-121618:0
Canonical exit: 19 Feb 2023 (T+90)
2 of 2 declarations
